| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0020-1383(08)70007-X |
| P698 | PubMed publication ID | 18224735 |
| P2093 | author name string | Wildemann B | |
| Schmidmaier G | |||
| Haas NP | |||
| Schwabe P | |||
| P2860 | cites work | Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy | Q53528538 |
| Donor site morbidity after anterior iliac crest bone harvest for single-level anterior cervical discectomy and fusion. | Q53659696 | ||
| Direct percutaneous gene delivery to enhance healing of segmental bone defects | Q64378068 | ||
| Osteointegration and implant position after cementless total knee replacement | Q73076490 | ||
| Effect of recombinant human bone morphogenetic protein-2 on fracture healing in a goat tibial fracture model | Q77301876 | ||
| Bone morphogenetic protein-2 increases the rate of callus formation after fracture of the rabbit tibia | Q77884641 | ||
| Iliac crest bone graft donor site pain after anterior lumbar interbody fusion: a prospective patient satisfaction outcome assessment | Q81379276 | ||
| Novel regulators of bone formation: molecular clones and activities | Q24297338 | ||
| Recombinant human bone morphogenetic protein induces bone formation | Q24303883 | ||
| Bone: formation by autoinduction | Q28251545 | ||
| Biodegradable poly(D,L-lactide) coating of implants for continuous release of growth factors | Q31926776 | ||
| Complications of posterior iliac crest bone grafting in spine surgery in children | Q34031189 | ||
| Factors stimulating bone formation | Q34444194 | ||
| Bone-grafting and bone-graft substitutes. | Q34557248 | ||
| Safety profile for the clinical use of bone morphogenetic proteins in the spine | Q34805743 | ||
| Modern issues in bone graft substitutes and advances in bone tissue technology | Q34965231 | ||
| Biophysical stimulation of bone fracture repair, regeneration and remodelling. | Q35628798 | ||
| Application of bone morphogenetic proteins in orthopaedic practice: their efficacy and side effects | Q36040760 | ||
| Current concepts of molecular aspects of bone healing | Q36231316 | ||
| Bone substitutes: an update | Q36269863 | ||
| Clinical applications of BMP-7: the UK perspective | Q36269886 | ||
| Allograft and alloplastic bone substitutes: a review of science and technology for the craniomaxillofacial surgeon | Q36331163 | ||
| Drugs and fracture repair | Q36392934 | ||
| Bone morphogenic protein science and studies | Q36396715 | ||
| The role of growth factors and related agents in accelerating fracture healing | Q36486920 | ||
| Economic considerations for the use of recombinant human bone morphogenetic protein-2 in open tibial fractures in Europe: the German model | Q36553890 | ||
| Bone grafts and bone graft substitutes in orthopaedic trauma surgery. A critical analysis | Q36748980 | ||
| Autologous iliac crest bone graft: should it still be the gold standard for treating nonunions? | Q36769413 | ||
| Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomized rats | Q36993997 | ||
| Differential repair responses in the coronal and radicular areas of the exposed rat molar pulp induced by recombinant human bone morphogenetic protein 7 (osteogenic protein 1). | Q38523393 | ||
| IGF-I and TGF-beta 1 incorporated in a poly(D,L-lactide) implant coating stimulates osteoblast differentiation and collagen-1 production but reduces osteoblast proliferation in cell culture | Q40664516 | ||
| Adult posttraumatic osteomyelitis of the tibial diaphysis of the tibial shaft. | Q40819414 | ||
| Telopeptide-depleted bovine skin collagen as a carrier for bone morphogenetic protein | Q41138879 | ||
| MicroCT evaluation of three-dimensional mineralization in response to BMP-2 doses in vitro and in critical sized rat calvarial defects | Q42830655 | ||
| Local delivery of growth factors from coated titanium plates increases osteotomy healing in rats | Q43461784 | ||
| Differences in the fusion and resorption activity of human osteoclasts after stimulation with different growth factors released from a polylactide carrier | Q45101823 | ||
| Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects | Q45867586 | ||
| Local application of growth factors (insulin-like growth factor-1 and transforming growth factor-beta1) from a biodegradable poly(D,L-lactide) coating of osteosynthetic implants accelerates fracture healing in rats. | Q46119541 | ||
| Pharmacokinetics and tissue distribution of recombinant human transforming growth factor beta 1 after topical and intravenous administration in male rats | Q46156939 | ||
| Evaluation of Ad-BMP-2 for enhancing fracture healing in an infected defect fracture rabbit model | Q47341415 | ||
| rhBMP‐2 injected in a calcium phosphate paste (α‐BSM) accelerates healing in the rabbit ulnar osteotomy model | Q47447442 | ||
| Osteoinduction capability of recombinant human bone morphogenetic protein-2 in intramuscular and subcutaneous sites: an experimental study | Q48002209 | ||
| Health economics: a cost analysis of treatment of persistent fracture non-unions using bone morphogenetic protein-7. | Q52854968 | ||
| Application of recombinant BMP-7 on persistent upper and lower limb non-unions. | Q52857031 | ||
| IGF-I and TGF-beta1 application by a poly-(D,L-lactide)-coated cage promotes intervertebral bone matrix formation in the sheep cervical spine. | Q52955982 | ||
| P921 | main subject | morphogenesis | Q815547 |
| P304 | page(s) | S35-41 | |
| P577 | publication date | 2007-09-01 | |
| P1433 | published in | Injury | Q15752765 |
| P1476 | title | Use of bone morphogenetic proteins for treatment of non-unions and future perspectives | |
| P478 | volume | 38 Suppl 4 |
| Q37274352 | A comparison of RhBMP-7 (OP-1) and autogenous graft for metaphyseal defects after osteotomy of the distal radius |
| Q37274331 | Allograft and bone morphogenetic proteins: an overview |
| Q37274323 | An update on recent advances in bone regeneration |
| Q52850799 | Application of BMP-7 to tibial non-unions: a 3-year multicenter experience. |
| Q52848242 | Application of bone morphogenetic proteins to femoral non-unions: a 4-year multicentre experience. |
| Q55033975 | Biomaterials for the Delivery of Growth Factors and Other Therapeutic Agents in Tissue Engineering Approaches to Bone Regeneration. |
| Q47216804 | Biomimetic Tissue-Engineered Bone Substitutes for Maxillofacial and Craniofacial Repair: The Potential of Cell Sheet Technologies |
| Q37834550 | Bone grafting, orthopaedic biomaterials, and the clinical need for bone engineering |
| Q45856385 | Bone morphogenetic proteins in critical-size bone defects: what are the options? |
| Q82551202 | Bone morphogenetic proteins in musculoskeletal medicine |
| Q37411083 | Can rhBMP-2 containing collagen sponges enhance bone repair in ovariectomized rats?: a preliminary study |
| Q37274336 | Carrier systems and application of growth factors in orthopaedics |
| Q44804281 | Dynamic contrast-enhanced magnetic resonance imaging can assess vascularity within fracture non-unions and predicts good outcome |
| Q37618597 | Efficacy of minimally invasive techniques for enhancement of fracture healing: evidence today |
| Q48822821 | Fracture healing: a consensus report from the International Osteoporosis Foundation Fracture Working Group |
| Q37274339 | Fracture vascularity and bone healing: a systematic review of the role of VEGF. |
| Q54577583 | Immunologically restricted patients exhibit a pronounced inflammation and inadequate response to hypoxia in fracture hematomas. |
| Q37343132 | Injectable biomaterials for regenerating complex craniofacial tissues. |
| Q36490760 | Mechanical load modulates the stimulatory effect of BMP2 in a rat nonunion model |
| Q45334685 | Monotherapy vs. polytherapy in the treatment of forearm non-unions and bone defects |
| Q56992545 | OP-1 application in bone allograft integration: preliminary results in sheep experimental surgery |
| Q64987834 | Osseointegrative effect of rhBMP-2 covalently bound on a titan-plasma-spray-surface after modification with chromosulfuric acid in a large animal bone gap-healing model with the Göttingen minipig. |
| Q34579496 | Preconditioning Human Mesenchymal Stem Cells with a Low Concentration of BMP2 Stimulates Proliferation and Osteogenic Differentiation In Vitro |
| Q37590051 | Review article: bone transplantation and immune response |
| Q34341186 | Shaping scaffold structures in rapid manufacturing implants: a modeling approach toward mechano-biologically optimized configurations for large bone defect. |
| Q33669589 | Stimulation of osteogenic differentiation in human osteoprogenitor cells by pulsed electromagnetic fields: an in vitro study. |
| Q36106613 | Studies of bone morphogenetic protein-based surgical repair |
| Q50543500 | Surface modification by glow discharge gasplasma treatment improves vascularization of allogenic bone implants. |
| Q36153143 | The treatment of nonunions with application of BMP-7 increases the expression pattern for angiogenic and inflammable cytokines: a matched pair analysis |
| Q37848276 | Tissue-engineered vascularized bone grafts: basic science and clinical relevance to trauma and reconstructive microsurgery |
Search more.